Dengue among febrile patients in Ghana: prevalence and facility-level variation in a multisite surveillance study
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
Dengue is under-recognized in Ghana, where laboratory testing is limited. We estimated dengue NS1 and/or IgM positivity among febrile patients and described geographical, temporal, and demographic variation.
Methodology
We conducted cross-sectional surveillance among consenting febrile patients aged ≥1 year at six public facilities in Greater Accra, Bono East, and Upper West between August 2023 and July 2025. We randomly selected one region within each of three ecological strata and selected facilities with high febrile-case volumes. We approached and recruited consecutive eligible patients. We tested serum for dengue NS1 antigen and IgM antibody by ELISA; positive NS1 samples underwent RT-PCR and serotyping. We estimated proportions with 95% confidence intervals (CI) and used logistic regression to examine adjusted associations.
Results
Among 2,936 participants, 204 were NS1- and/or IgM-positive (6.95%; 95% CI, 6.05-7.93%): 31 were NS1-only, 161 IgM-only, and 12 dual-positive. Prevalence ranged from 3.88% (95% CI, 2.19-6.31%) at Kintampo to 12.32% (9.56-15.55%) at Atebubu, both in Bono East. Adjusted odds increased with age (aOR per five years, 1.09; 95% CI, 1.05-1.14). Eight of 43 NS1-positive samples contained dengue RNA: five DENV-1 from Bono East and three DENV-3 from Upper West. There was no clear rainy-dry season difference.
Conclusions
Dengue NS1 and/or IgM were detected among febrile patients at all six facilities, and RT-PCR confirmed circulation of DENV-1 and DENV-3. These findings support including dengue in febrile illness evaluation and strengthening laboratory-supported surveillance in Ghana.
Author summary
Dengue is probably overlooked in Ghana because its symptoms resemble malaria and other common causes of fever, while laboratory testing is not routinely available. We studied 2,936 febrile patients who attended six public health facilities across three regions of Ghana. Blood samples were tested for a dengue protein found early in infection and for antibodies that usually appear later. Overall, 204 participants (6.95%; 95% confidence interval, 6.05-7.93%) had evidence of acute or recent dengue infection. Dengue was detected at every participating facility, but proportions varied considerably, even among facilities in the same region. Genetic testing detected dengue virus in eight samples and identified virus types 1 and 3. The chance of a positive result increased with age, although this difference was mainly related to antibody detection rather than the early-infection protein. We did not find a simple difference between rainy and dry seasons. Because the facilities were selected for their high numbers of patients with fever, the findings do not estimate dengue prevalence in the general population or across entire regions. They show that dengue contributes to febrile illness in Ghana and support continued surveillance that reports findings separately for individual facilities and diagnostic markers.